checkAd
    Startseite > Aktien > Prelude Therapeutics > Nachrichten
    Prelude Therapeutics Aktie
    4,0000
     
    USD
    +3,63 %
    +0,1400 USD
    Letzter Kurs 15.05.24 Nasdaq
    4,0000
     
    USD
    200 STK
    Geldkurs 15.05.24
    4,0700
     
    USD
    400 STK
    Briefkurs 15.05.24
    ISIN: US74065P1012 · WKN: A2QDGN · SYM: PRLD · USA

    Neueste Nachrichten

    Prelude Therapeutics to Participate in Citizens JMP Life Sciences Conference
    09.05.24 · globenewswire · Prelude Therapeutics
    Prelude Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
    07.05.24 · globenewswire · Prelude Therapeutics
    Prelude Highlights Continued Strength of Discovery Engine at 2024 AACR Annual Meeting
    09.04.24 · globenewswire · Prelude Therapeutics
    Prelude Announces Acceptance of Multiple Preclinical Abstracts at the 2024 AACR Annual Meeting
    05.03.24 · globenewswire · Prelude Therapeutics
    Prelude Therapeutics to Participate in Barclays Global Healthcare Conference
    29.02.24 · globenewswire · Prelude Therapeutics
    Prelude Therapeutics Reports Full Year 2023 Financial Results and Outlines Key Objectives for 2024
    15.02.24 · globenewswire · Prelude Therapeutics
    Prelude Announces Strategic Pipeline Progress and Updates, including its Partnership with AbCellera, and Reports Third Quarter Financial Results
    01.11.23 · globenewswire · Prelude Therapeutics
    Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Drug Conjugates in Oncology
    01.11.23 · Business Wire (engl.) · Prelude Therapeutics
    Prelude Announces Multiple Clinical and Preclinical Poster Presentations at AACR-NCI-EORTC International Conference 
    14.10.23 · globenewswire · Prelude Therapeutics
    Prelude Therapeutics to Participate in Three Healthcare Investor Conferences in September
    29.08.23 · globenewswire · Prelude Therapeutics
    Prelude Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Update
    03.08.23 · globenewswire · Prelude Therapeutics
    Prelude Therapeutics To Participate in Jefferies Healthcare Conference
    31.05.23 · globenewswire · Prelude Therapeutics